Vaxcyte Inc (PCVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PCVX | TECH | SRPT | ||
| Company | Vaxcyte Inc | Bio-Techne Corp | Sarepta Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 85.78 | 68.60 | 110.87 | ||
| High | 92.87 | 71.18 | 111.78 | ||
| Low | 85.33 | 68.42 | 109.03 | ||
| Last | 89.05 | 70.35 | 110.42 | ||
| Change | +3.09 | +1.63 | -0.44 | ||
| % Change | +3.59% | +2.37% | -0.40% | ||
| Volume | 1,176,001 | 643,871 | 448,511 | ||
| 20-Day Average Volume | 1,566,032 | 1,192,114 | 1,075,522 | ||
| Previous Close | 85.96 | 68.72 | 110.86 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 100.41 | 72.72 | 118.91 | ||
| 20-Day Raw Stochastic | 20.51% | 33.05% | 28.46% | ||
| 20-Day Relative Strength | 37.18% | 46.37% | 38.45% | ||
| Weighted Alpha | +39.89 | +3.33 | +2.11 | ||
| Today's Opinion | 24% Buy | 72% Sell | 88% Sell | ||
| Previous Opinion | 8% Buy | 72% Sell | 88% Sell | ||
| Last Month's Opinion | 88% Buy | 40% Sell | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.84% since 11/14/24 | -2.63% since 11/14/24 | +1.76% since 11/14/24 | ||
| Low | 84.52 on 11/18/24 | 65.61 on 11/20/24 | 102.15 on 11/18/24 | ||
| High | 92.87 on 11/21/24 | 72.46 on 11/15/24 | 111.38 on 11/20/24 | ||
| 1-Month | |||||
| %Chg | -21.20% since 10/21/24 | +0.38% since 10/21/24 | -12.78% since 10/21/24 | ||
| Low | 84.52 on 11/18/24 | 65.61 on 11/20/24 | 102.15 on 11/18/24 | ||
| High | 116.00 on 11/06/24 | 80.80 on 11/06/24 | 133.36 on 10/25/24 | ||
| 3-Month | |||||
| %Chg | +13.98% since 08/21/24 | -2.78% since 08/21/24 | -22.60% since 08/21/24 | ||
| Low | 77.21 on 08/28/24 | 65.61 on 11/20/24 | 102.15 on 11/18/24 | ||
| High | 121.06 on 09/19/24 | 80.95 on 09/19/24 | 144.22 on 08/22/24 | ||
| 6-Month | |||||
| %Chg | +23.52% since 05/21/24 | -14.57% since 05/21/24 | -14.01% since 05/21/24 | ||
| Low | 67.21 on 05/29/24 | 65.61 on 11/20/24 | 102.15 on 11/18/24 | ||
| High | 121.06 on 09/19/24 | 83.96 on 05/23/24 | 173.25 on 06/21/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,713,796 | 10,919,058 | 10,589,346 | ||
| Shares Outstanding, K | 124,637 | 158,892 | 95,520 | ||
| Annual Sales | 0 | 1,159,060,000 | 1,243,340,000 | ||
| Annual Net Income | -402,270,000 | 168,110,000 | -535,980,000 | ||
| Last Quarter Sales | 0 | 289,460,000 | 467,170,000 | ||
| Last Quarter Net Income | -103,120,000 | 33,600,000 | 33,610,000 | ||
| 60-Month Beta | 1.01 | 1.28 | 0.81 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.83 on 11/05/24 | 0.42 on 10/30/24 | 0.62 on 11/06/24 | ||
| Latest Earnings Date | 11/04/24 | 10/30/24 | 11/06/24 | ||
| Most Recent Dividend | N/A | 0.080 on 11/08/24 | N/A | ||
| Next Ex-Dividends Date | N/A | 11/08/24 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 40.72 | 91.91 | ||